• Leading the transition of gene therapies from preclinical to commercial stages through robust process development
• Optimizing cell culture, protein purification, and viral vector production for gene therapy applications
• Applying non-natural amino acid incorporation and DNA shuffling to advance gene editing technologies
• Developing quality control and analytical methods to support clinical and GMP manufacturing
• Collaborating across multi-site teams to align CMC strategy with clinical and commercial objectives